Authors


Gabriel Solorzano, MD

Latest:

Predictors of Poor Adherence to Follow-up Care in Survivors of Childhood Cancer

Rahiya Rehman, MD, and co-investigators, research the importance of poor follow-up and care for survivors of childhood cancer.



Zofia Piotrowska, MD

Latest:

OncView™ Podcast: EGFR Exon 20 Insertion as a Therapeutic Target in NSCLC

In an OncView™ program, Zofia Piotrowska, MD, touched on testing, treatment approaches, and therapeutic options for EGFR exon 20 insertion mutations in non–small cell lung cancer.



Juan Pablo Alderuccio, MD

Latest:

Oncology Peer Review On-The-Go: Current Treatments in Marginal Zone Lymphoma

Juan Pablo Alderuccio, MD, spoke with CancerNetwork® about a review article on the treatment of marginal zone lymphoma published in the journal ONCOLOGY®.



Farwa Zehra, MBBS

Latest:

Navigating a Paradigm Shift Venetoclax Treatment Redefines Landscape of Acute Myeloid Leukemia

Investigators focused on the latest advances in the treatment of patients with AML, while prioritizing the use of venetoclax as it has been shown to significantly impact the course of the disease.





Ramez Eskander, MD

Latest:

Data May Support Pembrolizumab/Chemo as New SOC in Endometrial Cancer

Although immature, overall survival data from the KEYNOTE-868 trial may support the use of pembrolizumab plus chemotherapy in patients with endometrial cancer.



Steven Vogl, MD

Latest:

HER2+ Advanced Breast Cancer: Selecting Third-Line Therapy

Sara A. Hurvitz, MD, and Steven E. Vogl, MD, discuss clinical implications of a recently published review of third-line therapy options for patients with HER2-positive metastatic breast cancer.


Andrés Gómez De León, MD

Latest:

Tandem 2022 Presentation: Haploidentical versus Matched Unrelated Donor Transplants for Lymphomas Using Post-transplant Cyclophosphamide

This article was written for and by CancerNetwork partner, the American Society for Transplantation and Cellular Therapy.





Ishmael Applewhite, BSN, RN-BC, OCN

Latest:

Administering CAR T-Cell Therapy and Bispecific Agents in Nursing Practice

Registered nurses discuss research related to agents like ciltacabtagene autoleucel presented at the 2024 Oncology Nursing Society Congress.


Nirav Patil, MBBS, MPH

Latest:

The Negative Impact of the COVID-19 Pandemic on Oncology Care at an Academic Cancer Referral Center

COVID-19 created unexpected delays in oncologic treatment. This study sought to assess the volume of missed cancer-related services due to the pandemic.



Vinit Makkar, MD

Latest:

Key Takeaways from the PARADIGM Study

Drs Gupta and Makkar conclude their discussion by highlighting key takeaways from the PARADIGM study and future directions that may address unmet needs in the field of la/mUC.





Basilio Pecorino, MD

Latest:

Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy

A survey was conducted in Italy for survivors of gynecologic cancer regarding quality of life, specifically that of sexual activity after a cancer diagnosis.



Trevor J. Pugh, PhD

Latest:

Trevor J. Pugh, PhD, on Reducing the Burden of Serial Testing for MMRd With 1 Sequencing Protocol

CancerNetwork® sat down with Trevor J. Pugh, PhD, to discuss a novel protocol for detecting mismatch repair deficiency.


Natasha Garg, DO, MS

Latest:

Looking Ahead in the Multiple Myeloma Treatment Landscape

Experts from City of Hope close out their panel on multiple myeloma management by identifying unmet needs and sharing what excites them in the future evolution of the treatment landscape.


Hans Kristian Nugraha, MD, SpOT

Latest:

An Arthroscopic Approach for the Intralesional Curettage of Giant Cell Tumor of the Distal Femur: A Case Report

Hans Kristian Nugraha, MD, SpOT, and colleagues detail the potential benefits of an arthroscopic surgical approach through a case study of a patient with giant cell tumor of bone.


Jill S. Barnholtz-Sloan, PhD

Latest:

The Negative Impact of the COVID-19 Pandemic on Oncology Care at an Academic Cancer Referral Center

COVID-19 created unexpected delays in oncologic treatment. This study sought to assess the volume of missed cancer-related services due to the pandemic.